Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Myocarditis Clinical Trials
Myocarditis clinical trials are recruiting across 16 cities. Here are the cities with the most active studies:
Myocarditis Trial Phases
4 research organizations are sponsoring myocarditis trials.
About Myocarditis
Myocarditis is inflammation of the heart muscle, often caused by viral infections, and can weaken the heart and cause arrhythmias. Symptoms range from mild chest pain to severe heart failure. Treatment focuses on managing symptoms and addressing the underlying cause.
Clinical trials are advancing new treatments for myocarditis. Currently, 4 studies are recruiting a combined 1,038 participants across the United States. Research is being conducted by 4 organizations including Massachusetts General Hospital, Niguarda Hospital, Medical University of South Carolina and 1 others.
2026 Myocarditis Research Landscape
As of July 2026, the myocarditis clinical trial landscape includes 4 actively recruiting studies across 16 cities in the United States. These studies are collectively seeking 1,038 participants, with an average enrollment target of 260 per study.
The research spans multiple phases of development: 2 studies are in PHASE3, 2 studies are in NA. The presence of Phase 3 trials indicates that some myocarditis treatments are in late-stage testing and may be approaching regulatory review.
Research is being led by 4 different organizations, including Massachusetts General Hospital, Niguarda Hospital, Medical University of South Carolina, Nabeel Hamzeh.
Geographically, myocarditis trials are most concentrated in Los Angeles, California (1 trial); Washington D.C., District of Columbia (1 trial); Tampa, Florida (1 trial); Chicago, Illinois (1 trial); Indianapolis, Indiana (1 trial) and 7 other cities.
Featured Myocarditis Studies
Highlighted recruiting studies for myocarditis, selected by enrollment size and research scope.
Abatacept in Immune Checkpoint Inhibitor Myocarditis
The primary aim is to test whether abatacept, as compared to placebo, is associated with a reduction in major adverse cardiac events (MACE) among participants hospitalized with myocarditis secondary to an immune checkpoint inhibitor (ICI). The primary outcome, MACE, is a composite of first occurrence of cardiovascular death, non-fatal sudden cardiac arrest, cardiogenic shock, significant ventricul...
MYTHS - MYocarditis THerapy With Steroids
This is a phase III, multi-center international, single blind randomized controlled trial to test the efficacy of pulsed intravenous (IV) methylprednisolone versus standard therapy on top of maximal support in patients with Acute myocarditis (AM).
Quantitative Cardiac Parametric Mapping
The overall goal of this project is to evaluate the clinical potential of fast quantitative myocardial tissue characterization using recently emerged Cardiac Magnetic Resonance Imaging (CMR) techniques to aid the diagnosis, treatment, and follow up of patients with myocardial diseases, such as ischemic heart disease, cardiomyopathies, and myocarditis.
Frequently Asked Questions About Myocarditis Clinical Trials
Are there myocarditis clinical trials near me?
Yes, there are 4 myocarditis clinical trials currently recruiting across 16+ cities in the United States, including Los Angeles, California; Washington D.C., District of Columbia; Tampa, Florida. Browse the studies above to find one at a location convenient for you.
How do I join a myocarditis clinical trial?
To join a myocarditis clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are myocarditis clinical trials free?
Yes, participation in myocarditis clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of myocarditis treatments are being studied?
Current myocarditis clinical trials are testing a range of approaches across PHASE3 (2 studies), NA (2 studies). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 4 research organizations.
Is it safe to participate in myocarditis clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated July 16, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated July 16, 2026 · Data from ClinicalTrials.gov